Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- PMID: 21423189
- DOI: 10.1038/nbt.1807
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Abstract
To realize the therapeutic potential of RNA drugs, efficient, tissue-specific and nonimmunogenic delivery technologies must be developed. Here we show that exosomes-endogenous nano-vesicles that transport RNAs and proteins-can deliver short interfering (si)RNA to the brain in mice. To reduce immunogenicity, we used self-derived dendritic cells for exosome production. Targeting was achieved by engineering the dendritic cells to express Lamp2b, an exosomal membrane protein, fused to the neuron-specific RVG peptide. Purified exosomes were loaded with exogenous siRNA by electroporation. Intravenously injected RVG-targeted exosomes delivered GAPDH siRNA specifically to neurons, microglia, oligodendrocytes in the brain, resulting in a specific gene knockdown. Pre-exposure to RVG exosomes did not attenuate knockdown, and non-specific uptake in other tissues was not observed. The therapeutic potential of exosome-mediated siRNA delivery was demonstrated by the strong mRNA (60%) and protein (62%) knockdown of BACE1, a therapeutic target in Alzheimer's disease, in wild-type mice.
Comment in
-
SiRNA delivery with exosome nanoparticles.Nat Biotechnol. 2011 Apr;29(4):325-6. doi: 10.1038/nbt.1830. Nat Biotechnol. 2011. PMID: 21478846 No abstract available.
-
Getting RNAi therapies to the brain.Nat Rev Genet. 2011 May;12(5):296. doi: 10.1038/nrg2990. Nat Rev Genet. 2011. PMID: 21499291 No abstract available.
-
A new endogenous and immunologically inert siRNA delivery vehicle for targeting the brain.Nanomedicine (Lond). 2011 Sep;6(7):1157-8. Nanomedicine (Lond). 2011. PMID: 22029061 No abstract available.
Similar articles
-
Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease.J Control Release. 2018 Jun 10;279:220-233. doi: 10.1016/j.jconrel.2018.04.034. Epub 2018 Apr 19. J Control Release. 2018. PMID: 29679667
-
A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain.J Control Release. 2016 Apr 28;228:120-131. doi: 10.1016/j.jconrel.2016.03.007. Epub 2016 Mar 4. J Control Release. 2016. PMID: 26948382
-
Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer's Disease.Int J Nanomedicine. 2025 May 6;20:5873-5891. doi: 10.2147/IJN.S506793. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40351705 Free PMC article.
-
Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.Adv Drug Deliv Rev. 2013 Mar;65(3):348-56. doi: 10.1016/j.addr.2012.07.006. Epub 2012 Jul 20. Adv Drug Deliv Rev. 2013. PMID: 22820525 Free PMC article. Review.
-
Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.J Drug Target. 2020 Feb;28(2):129-141. doi: 10.1080/1061186X.2019.1641508. Epub 2019 Aug 12. J Drug Target. 2020. PMID: 31280623 Review.
Cited by
-
A comprehensive review of challenges and advances in exosome-based drug delivery systems.Nanoscale Adv. 2024 Oct 29;6(23):5803-26. doi: 10.1039/d4na00501e. Online ahead of print. Nanoscale Adv. 2024. PMID: 39484149 Free PMC article. Review.
-
Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor.Adv Sci (Weinh). 2021 Mar 16;8(10):2002787. doi: 10.1002/advs.202002787. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 34026432 Free PMC article.
-
Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis.Life (Basel). 2022 Sep 11;12(9):1417. doi: 10.3390/life12091417. Life (Basel). 2022. PMID: 36143453 Free PMC article. Review.
-
Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases.Front Immunol. 2021 Mar 25;12:636222. doi: 10.3389/fimmu.2021.636222. eCollection 2021. Front Immunol. 2021. PMID: 33841418 Free PMC article.
-
CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.Pharm Res. 2023 Jan;40(1):77-105. doi: 10.1007/s11095-022-03433-5. Epub 2022 Nov 15. Pharm Res. 2023. PMID: 36380168 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials